The immunotherapy BCG is in short supply in the United States. The American Urological Association and other groups have responded with a set of treatment strategies for clinicians, but problems are piling up.
Medscape Medical News
Original Article: No End in Sight, Bladder Cancer Drug Shortage Takes a Toll